City

Shenzhen (1)

Condition

Chronic Myeloid Leukemia, Chronic Phase (1)

Olverembatinib (1)

Tyrosine Kinase Inhibitors (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Shenzhen Second People's Hospital (1)

Collaborator

Intervention

olverembatinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

olverembatinib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

Recruiting

Olverembatinib
+2 more

olverembatinib

Shenzhen, Guangdong, China

Shenzhen Second People's Hospital

Jul 26, 2022